$Roivant Sciences (ROIV.US)$ extremely undervalued, by at le...

$Roivant Sciences (ROIV.US)$ extremely undervalued, by at least 60%? Roivant stock was already priced at ~ $7 with a market cap of $5 Billion when it licensed RVT-3101 from Pfizer for $45 million back in Dec, 2022. Now Roivant just pocketed $5 billion from selling it to Roche, so its stock price shall at least raise to $14 to justify the huge gain only from the Roche deal by simple math, that's probably also why its average analyst price target is about $16.